Effect of rifampicin induced S9 fraction on the mutagenicity of isoniazid in the Salmonella assay system
Polasa, K.; Krishnaswamy, K.
Indian Journal of Medical Research 86: 232-236
1987
ISSN/ISBN: 0019-5340 PMID: 3428956 Document Number: 303894
Document emailed within 1 workday
Related Documents
Wollin, K-M.; Gorlitz, B-D. 2004: Comparison of genotoxicity of textile dyestuffs in Salmonella mutagenicity assay, in vitro micronucleus assay, and single cell gel/comet assay Journal of Environmental Pathology Toxicology and Oncology: Official Organ of the International Society for Environmental Toxicology and Cancer 23(4): 267-278Ampy, F.R.; Saxena, S.; Verma, K. 1988: Mutagenicity of benzo(a)pyrene in uninduced tissues from BALB/c mice and Sprague-Dawley rats as an index of possible health risks using the Salmonella mutagenicity assay Cytobios 56(225): 81-87
Tayal, V.; Kalra, B.S.; Agarwal, S.; Khurana, N.; Gupta, U. 2007: Hepatoprotective effect of tocopherol against isoniazid and rifampicin induced hepatotoxicity in albino rabbits Indian Journal of Experimental Biology 45(12): 1031-1036
Dunkel, V.C. 1979: Collaborative studies on the Salmonella/microsome mutagenicity assay Journal - Association of Official Analytical Chemists 62(4): 874-882
Marche, J.; Hugues, F.C.; Graisely, B.; Marche, C. 1971: Hepatitis induced by combination of rifampicin and isoniazid Annales de Medecine Interne 122(10): 1045-1054
Kasantikul, V. 1989: Isoniazid-rifampicin-induced submassive hepatic necrosis Journal of the Medical Association of Thailand 72(1): 56-58
Anderson, D.; Blowers, S.D.; Craddock, V.M. 1985: The effects of S9 mix from rat oesophagus, salivary gland, and liver on the mutagenicity of the rat oesophageal carcinogen N-nitroso-N-methylaniline in the Salmonella typhimurium assay Mutation Research 142(1-2): 13-18
Rossolini, A.; Cellesi, C.; Debolini, A. 1973: Experimental study of liver damage due to rifampicin and rifampicin-isoniazid combination Il Farmaco; Edizione Pratica 28(6): 345-355
Panchagnula, R.; Singh, I.; Kaur, K.J.; Kaul, C.L. 1999: Bioequivalence study of rifampicin in fixed-dose combination of rifampicin and isoniazid vs. separate formulations Methods and Findings in Experimental and Clinical Pharmacology 21(9): 625-628
Ramachandran, G.; Hemanth Kumar, A.K.; Srinivasan, R.; Geetharani, A.; Sugirda, P.; Nandhakumar, B.; Nandini, R.; Tharani, C.B. 2012: Effect of rifampicin and isoniazid on the steady state pharmacokinetics of moxifloxacin Indian Journal of Medical Research 136(6): 979-984
Richard, C.; Quevauvilliers, J. 1983: Acute adrenal insufficiency induced by antitubercular treatment in an addisonian woman. Possible role of the rifampicin-isoniazid combination Presse Medicale 12(12): 767-768
Coban, A.Y.; Bilgin, K.; Uzun, M.; Durupinar, B. 2009: Effect of linezolid in combination with isoniazid and rifampicin against multidrug resistant Mycobacterium tuberculosis clinical isolates Mikrobiyoloji Bulteni 43(2): 293-297
Wirth, P.J.; Thorgeirsson, S.S. 1981: Mechanism of N-hydroxy-2-acetylaminofluorene mutagenicity in the Salmonella test system. Role of N-O acyltransferase and sulfotransferase from rat liver Molecular Pharmacology 19(2): 337-344
Wirth, P.J.; Dybing, E.; von Bahr, C.; Thorgeirsson, S.S. 1980: Mechanism of N-hydroxyacetylarylamine mutagenicity in the Salmonella test system: metabolic activation of N-hydroxyphenacetin by liver and kidney fractions from rat, mouse, hamster, and man Molecular Pharmacology 18(1): 117-127
Ogawa, S.; Hirayama, T.; Nohara, M.; Tokuda, M.; Hirai, K.; Fukui, S. 1985: The effect of quercetin on the mutagenicity of 2-acetylaminofluorene and benzo[alpha]pyrene in Salmonella typhimurium strains Mutation Research 142(3): 103-107
Bonora, G.; De La Pierre, L.; Perletti, L. 1981: Hepatotoxicity of the rifampicin-isoniazid combination in children Minerva Pediatrica 33(16): 835-836
Karkishchenko, N.N.; Khoron'ko, V.V.; Vorob'ev, V.S.; Anisimova, N.B.; Chubarian, V.T. 1987: Clinico-pharmacological approach to rifampicin and isoniazid dosage Problemy Tuberkuleza 9: 31-34
Skakun, N.P.; Tabachuk, O.E. 1991: Comparative hepatic toxicity of isoniazid, rifampicin and ethambutol Problemy Tuberkuleza 1991(10): 77-79
Volosevich, G.V. 1989: Hepatitis during rifampicin and isoniazid treatment of a patient with generalized tuberculosis Problemy Tuberkuleza 9: 72-73
Lo Schiavo, A.; Cozzi, R.; Alfano, R.; Romano, F.; La Montagna, M.; Caccavale, T.; Capasso, R.; Mea, E.E.; Caccavale, S. 2014: A case of tuberculosis cutis colliquativa treated with rifampicin and isoniazid Acta Dermatovenerologica Croatica: Adc 22(2): 160-161